Serum fibroblast growth factor-21 shows a stronger association with liver stiffness than fetuin-a in adults with type 2 diabetes mellitus undergoing non-invasive liver assessment: a cross-sectional study
Acta Diabetologica · 16.11.2026
DOI: 10.1007/s00592-026-02820-3 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Acta Diabetologica, online erschienen am 16.11.2026. Verfasst von Surender und 5 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Surender, Khatana, P., Rajput, R., Mishra, S. K., Kuchay, M. S., & Surjeet (2026). Serum fibroblast growth factor-21 shows a stronger association with liver stiffness than fetuin-a in adults with type 2 diabetes mellitus undergoing non-invasive liver assessment: a cross-sectional study. Acta Diabetologica. https://doi.org/10.1007/s00592-026-02820-3
Vancouver
Surender, Khatana P, Rajput R, Mishra SK, Kuchay MS, Surjeet. Serum fibroblast growth factor-21 shows a stronger association with liver stiffness than fetuin-a in adults with type 2 diabetes mellitus undergoing non-invasive liver assessment: a cross-sectional study. Acta Diabetologica. 2026. doi:10.1007/s00592-026-02820-3
BibTeX
@article{Surender2026,
author = {Surender and Khatana, Pushpender and Rajput, Rajesh and Mishra, Sunil Kumar and Kuchay, Mohammad Shafi and Surjeet},
title = {Serum fibroblast growth factor-21 shows a stronger association with liver stiffness than fetuin-a in adults with type 2 diabetes mellitus undergoing non-invasive liver assessment: a cross-sectional study},
journal = {Acta Diabetologica},
year = {2026},
doi = {10.1007/s00592-026-02820-3}
}
EUVIMED